74 related articles for article (PubMed ID: 3357004)
1. Evolution of erythrocyte sedimentation rate as predictor of early relapse in posttherapy early-stage Hodgkin's disease.
Friedman S; Henry-Amar M; Cosset JM; Carde P; Hayat M; Dupouy N; Tubiana M
J Clin Oncol; 1988 Apr; 6(4):596-602. PubMed ID: 3357004
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic implications and sites of relapse predicted by elevated posttherapy erythrocyte sedimentation rate in early stage Hodgkin disease.
Friedman S; Henry-Amar M; Cosset JM; Carde P; Hayat M; Dupouy N; Tubiana M
Am J Hematol; 1991 Aug; 37(4):253-7. PubMed ID: 1858782
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of erythrocyte sedimentation rate in clinical stages I-II of Hodgkin's disease.
Tubiana M; Henry-Amar M; Burgers MV; van der Werf-Messing B; Hayat M
J Clin Oncol; 1984 Mar; 2(3):194-200. PubMed ID: 6366151
[TBL] [Abstract][Full Text] [Related]
4. Erythrocyte sedimentation rate predicts early relapse and survival in early-stage Hodgkin disease. The EORTC Lymphoma Cooperative Group.
Henry-Amar M; Friedman S; Hayat M; Somers R; Meerwaldt JH; Carde P; Burgers JM; Thomas J; Monconduit M; Noordijk EM
Ann Intern Med; 1991 Mar; 114(5):361-5. PubMed ID: 1992877
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of erythrocyte sedimentation rate, C-reactive protein and serum lactate dehydrogenase levels in the diagnosis, prognosis and treatment monitoring of children suffering from cancer].
Bień E; Balcerska A
Med Wieku Rozwoj; 2004; 8(4 Pt 2):1081-9. PubMed ID: 15951603
[TBL] [Abstract][Full Text] [Related]
6. New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group.
Josting A; Franklin J; May M; Koch P; Beykirch MK; Heinz J; Rudolph C; Diehl V; Engert A
J Clin Oncol; 2002 Jan; 20(1):221-30. PubMed ID: 11773173
[TBL] [Abstract][Full Text] [Related]
7. A multivariate analysis of prognostic factors in early stage Hodgkin's disease.
Tubiana M; Henry-Amar M; van der Werf-Messing B; Henry J; Abbatucci J; Burgers M; Hayat M; Somers R; Laugier A; Carde P
Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):23-30. PubMed ID: 3881375
[TBL] [Abstract][Full Text] [Related]
8. Prognostic markers of disease activity in Hodgkin's disease.
Martinow AJ; Yuen K; Cooper IA; Matthews JP; Juneja S; Wolf M; Januszewicz H; Prince HM
Leuk Lymphoma; 1998 Apr; 29(3-4):383-9. PubMed ID: 9684935
[TBL] [Abstract][Full Text] [Related]
9. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C
Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953
[TBL] [Abstract][Full Text] [Related]
10. Late relapse in early-stage Hodgkin's disease patients enrolled on European Organization for Research and Treatment of Cancer protocols.
Bodis S; Henry-Amar M; Bosq J; Burgers JM; Mellink WA; Dietrich PY; Dupouy N; Noordijk EM; Raemaekers JM; Thomas J
J Clin Oncol; 1993 Feb; 11(2):225-32. PubMed ID: 8426198
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the prognostic meaning of C-reactive protein (CRP) in children and adolescents with classical Hodgkin's lymphoma (HL).
Haase R; Vilser C; Mauz-Körholz C; Hasenclever D; Kluge R; Ruschke K; Borkhardt A; Seeger K; Lehrnbecher T; Kulozik A; Rößler J; Burdach S; Jürgens H; Körholz D
Klin Padiatr; 2012 Oct; 224(6):377-81. PubMed ID: 23047832
[TBL] [Abstract][Full Text] [Related]
12. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
Bien E; Balcerska A
Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
[TBL] [Abstract][Full Text] [Related]
13. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
Mjaaland I; Ganser D; Freitag EM; Bohndorf W
Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of PET using 18F-FDG in Hodgkin's disease for posttreatment evaluation.
Guay C; Lépine M; Verreault J; Bénard F
J Nucl Med; 2003 Aug; 44(8):1225-31. PubMed ID: 12902411
[TBL] [Abstract][Full Text] [Related]
15. Hodgkin's disease: a quantitative evaluation by computed tomography of tumor burden.
Torricelli P; Grimaldi PL; Fiocchi F; Federico M; Romagnoli R
Clin Imaging; 2004; 28(4):239-44. PubMed ID: 15246472
[TBL] [Abstract][Full Text] [Related]
16. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow involvement in Hodgkin's disease: an analysis of 135 consecutive cases. German Hodgkin's Lymphoma Study Group.
Munker R; Hasenclever D; Brosteanu O; Hiller E; Diehl V
J Clin Oncol; 1995 Feb; 13(2):403-9. PubMed ID: 7844601
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of prognosis using the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
BJU Int; 2015 Apr; 115(4):587-94. PubMed ID: 24947340
[TBL] [Abstract][Full Text] [Related]
19. [Does the residual mediastinal mass have prognostic significance in children with Hodgkin's disease (HD)?].
Klekawka T; Balwierz W; Moryl-Bujakowska A; Stanuch H; Matysiak M; Rokicka-Milewska R; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Chaber R; Sońita-Jakimczyki D; Janik-Moszants A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Adamkiewicz-Drozyińska E; Wysocki M; Koltan A; Krawczuk-Rybako M; Muszyńska-Rosłan K; Stolarska M
Przegl Lek; 2006; 63(1):21-4. PubMed ID: 16892894
[TBL] [Abstract][Full Text] [Related]
20. Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: long-term results of a randomized trial of radiotherapy alone.
Dühmke E; Franklin J; Pfreundschuh M; Sehlen S; Willich N; Rühl U; Müller RP; Lukas P; Atzinger A; Paulus U; Lathan B; Rüffer U; Sieber M; Wolf J; Engert A; Georgii A; Staar S; Herrmann R; Beykirch M; Kirchner H; Emminger A; Greil R; Fritsch E; Koch P; Drochtert A; Brosteanu O; Hasenclever D; Loeffler M; Diehl V
J Clin Oncol; 2001 Jun; 19(11):2905-14. PubMed ID: 11387364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
